A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

NCT07271069 ·Status: RECRUITING

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

NCT01647516 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05644665 ·Status: TERMINATED ·Phase: PHASE3

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

NCT05076175 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769 ·Status: COMPLETED ·Phase: PHASE3

Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis

NCT05809583 ·Status: WITHDRAWN

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

NCT00904878 ·Status: RECRUITING

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

NCT01612039 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Safety of IBD Drugs During Pregnancy and Breasfeeding: Mothers and Babies' Outcomes

NCT06337565 ·Status: RECRUITING

Basiliximab in Moderate to Severe Ulcerative Colitis

NCT00430898 ·Status: COMPLETED ·Phase: PHASE2

Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success

NCT05702879 ·Status: RECRUITING

Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study

NCT00486031 ·Status: COMPLETED ·Phase: PHASE3

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

NCT06311123 ·Status: RECRUITING

Population Based Evaluation of the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases

NCT03134508 ·Status: COMPLETED

A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

NCT00787202 ·Status: COMPLETED ·Phase: PHASE2

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

NCT00269438 ·Status: COMPLETED ·Phase: PHASE3

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

NCT00209300 ·Status: COMPLETED ·Phase: PHASE3

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis

NCT02818543 ·Status: COMPLETED ·Phase: PHASE1

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

NCT03464097 ·Status: TERMINATED ·Phase: PHASE3

Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis

NCT04353791 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity.

NCT03504930 ·Status: UNKNOWN

The IUSS Crohn's Study: A Feasibility Study

NCT03939117 ·Status: COMPLETED